Kiniksa Pharmaceuticals International, plc (KNSA) — Dilution Risk Analysis

Current Snapshot

Kiniksa Pharmaceuticals International, plc (KNSA) has a DilutionWatch score of 16/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
68,444,061 Source
Public Float
40,084,706 Source
Float as % of Outstanding
58.6%

Dilution Risk Score

Score: 16/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 10.

FormFiledAccession
4 2026-09-03 0001464583-26-000008
4 2026-09-03 0001857177-26-000008
4 2026-09-03 0001741533-26-000010
4 2026-09-03 0001532218-26-000014
4 2026-09-03 0001532218-26-000016
4 2026-09-03 0001835458-26-000012
4 2026-05-01 0001532218-26-000008
4 2026-04-30 0001532218-26-000006
4 2026-04-29 0001384243-26-000010
4 2026-04-13 0001857177-26-000006

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 999 months Source
Three-year share count growth 10.0% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 16/10) Source
Cash Runway
999 months Source
Share Count Growth (3-Year)
10.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.